Drugs / PF-03187207
Trials 2 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00595101 | Dec 2007 → Jun 2008 | ocular hypertension, open-angle glaucoma | Bausch & Lomb Incorporated | Completed | No outcome recorded |
| Phase 2 | NCT00441883 | Mar 2007 → Feb 2008 | exfoliation syndrome, ocular hypertension, open-angle glaucoma | Bausch & Lomb Incorporated | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-03187207 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00595101 ↗ |
| Route | Other | “One drop of each, once daily in study eye for 28 days” NCT00441883 ↗ |